1-1 of 1
Paul Kassner, PhD
Close
Sort by
Journal Articles

FLX925 Is a Rationally Designed FLT3, CDK4/6 Inhibitor with a Desirable Resistance Profile

Sachie Marubayashi, M.S., Adam Park, B.S., Rajkumar Noubade, PhD, Huyen Phan, B.S., Gene Cutler, PhD, Paul Kassner, PhD, Jordan S Fridman, PhD
Journal: Blood
Blood (2016) 128 (22): 2323.
https://doi.org/10.1182/blood.V128.22.2323.2323
Published: 2016